MagForce AG (BST:MF6)

Market Cap	122.29K +14.3%
Revenue (ttm)	1.08M -28.3%
Net Income	-10.57M
EPS	-0.35
Shares Out	30.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,137
Open	0.0040
Previous Close	0.0040
Day's Range	0.0040 - 0.0045
52-Week Range	0.0010 - 0.0180
Beta	-6.39
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MagForce AG

MagForce AG develops advanced nanomedicine for cancer therapies. It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Employees: 33
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: MF6